- Home
- RDCM vs NGNE Comparison
RDCM vs NGNE Comparison
Compare RDCM & NGNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RDCM
- NGNE
- Stock Information
- Founded
- RDCM 1985
- NGNE 2003
- Country
- RDCM Israel
- NGNE United States
- Employees
- RDCM 295
- NGNE N/A
- Industry
- RDCM Computer peripheral equipment
- NGNE Biotechnology: Pharmaceutical Preparations
- Sector
- RDCM Technology
- NGNE Health Care
- Exchange
- RDCM Nasdaq
- NGNE Nasdaq
- Market Cap
- RDCM 203.4M
- NGNE 230.0M
- IPO Year
- RDCM 1997
- NGNE N/A
- Fundamental
- Price
- RDCM $12.81
- NGNE $17.36
- Analyst Decision
- RDCM Strong Buy
- NGNE Strong Buy
- Analyst Count
- RDCM 2
- NGNE 6
- Target Price
- RDCM $15.00
- NGNE $60.80
- AVG Volume (30 Days)
- RDCM 146.7K
- NGNE 277.9K
- Earning Date
- RDCM 02-12-2025
- NGNE 11-18-2024
- Dividend Yield
- RDCM N/A
- NGNE N/A
- EPS Growth
- RDCM 79.17
- NGNE N/A
- EPS
- RDCM 0.43
- NGNE N/A
- Revenue
- RDCM $61,009,000.00
- NGNE $925,000.00
- Revenue This Year
- RDCM $13.44
- NGNE N/A
- Revenue Next Year
- RDCM $11.00
- NGNE N/A
- P/E Ratio
- RDCM $29.79
- NGNE N/A
- Revenue Growth
- RDCM 18.23
- NGNE N/A
- 52 Week Low
- RDCM $8.52
- NGNE $14.42
- 52 Week High
- RDCM $15.98
- NGNE $74.49
- Technical
- Relative Strength Index (RSI)
- RDCM 45.02
- NGNE 44.25
- Support Level
- RDCM $12.58
- NGNE $16.72
- Resistance Level
- RDCM $13.88
- NGNE $19.97
- Average True Range (ATR)
- RDCM 1.04
- NGNE 2.39
- MACD
- RDCM -0.18
- NGNE 0.08
- Stochastic Oscillator
- RDCM 20.15
- NGNE 19.43
About RDCM Radcom Ltd.
Radcom Ltd Ltd is engaged in providing network intelligence, 5G ready cloud-native, network intelligence solutions for telecom operators transitioning to 5G. The company has a network intelligence solution for 5G namely Radcom ACE. Its products consist of Radcom Network Visibility, Radcom Service Assurance, and Radcom Network Insights. It has offices in Israel, the United States, Brazil, and India. Key revenue is derived from sales in North America.
About NGNE Neurogene Inc.
Neurogene Inc is a clinical stage biotechnology company whose objective is to harness the power of gene therapy which is combined with its EXACT gene regulation technology to turn today's complex devastating neurological diseases into treatable conditions.